| P50 | author | Harry Comber | Q56451969 |
| P2093 | author name string | Linda Sharp | |
| | Anne-Elie Carsin | |
| | Frances J Drummond | |
| P2860 | cites work | The European Randomized Study of Screening for Prostate Cancer (ERSPC) | Q73192722 |
| | General practitioners' perceptions of medicolegal risk. Using case scenarios to assess the potential impact of prostate cancer screening guidelines | Q73255503 |
| | How underlying patient beliefs can affect physician-patient communication about prostate-specific antigen testing | Q74377784 |
| | Knowledge translation: closing the evidence-to-practice gap | Q79329736 |
| | Questionnaire order significantly increased response to a postal survey sent to primary care physicians | Q80451303 |
| | Integrating research, practice, and policy: what we see depends on where we stand | Q80739741 |
| | Will men attribute fault to their GP for adverse effects arising from controversial screening tests? An Australian study using scenarios about PSA screening | Q81057320 |
| | Major inter-laboratory variations in PSA testing practices: results from national surveys in Ireland in 2006 and 2007. | Q46405747 |
| | Rates of prostate-specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross-sectional study | Q47291827 |
| | What are the ingredients for a successful evidence-based patient choice consultation?: A qualitative study | Q47565507 |
| | Research on changing practitioner and patient behavior | Q47581287 |
| | Avoidance of anticipated regret: the ordering of prostate-specific antigen tests. | Q47750427 |
| | Evidence of prostate cancer screening in a UK region | Q47863461 |
| | A study of PSA requests from general practitioners received by one Dublin hospital. | Q48003149 |
| | An educational workshop on the early detection of prostate cancer--a before-after evaluation. | Q50751361 |
| | Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) - Results from a prospective, population-based, randomised study. | Q50893920 |
| | Why do primary care physicians in the United States and France order prostate-specific antigen tests for asymptomatic patients? | Q51019734 |
| | Translating Science to Practice | Q57749260 |
| | Rising incidence of prostate cancer in Scotland: increased risk or increased detection? | Q61851946 |
| | Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends | Q61881628 |
| | Screening for prostate cancer | Q24245476 |
| | PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK | Q24814107 |
| | Prostate cancer screening practices and beliefs | Q30309005 |
| | Dietary fat and prostate cancer: current status | Q33539814 |
| | Legal pitfalls in the diagnosis of prostate cancer | Q33994245 |
| | Factors influencing use of the prostate-specific antigen screening test in primary care | Q34025574 |
| | Family history and the risk of prostate cancer | Q34268953 |
| | Estimates of the cancer incidence and mortality in Europe in 2006. | Q34575047 |
| | Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback | Q35035387 |
| | "It's a maybe test": men's experiences of prostate specific antigen testing in primary care | Q36095195 |
| | Urological referral of asymptomatic men in general practice in England | Q36608520 |
| | Economic evaluation of prostate cancer screening with prostate-specific antigen. | Q37124961 |
| | Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial of the National Cancer Institute | Q39370564 |
| | Prostate cancer screening--a physician survey in Missouri | Q39478413 |
| | Knowledge, attitudes and experience associated with testing for prostate cancer: a comparison between male doctors and men in the community | Q39603999 |
| | Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma. | Q39645517 |
| | Screening for prostate cancer: a survey of New Zealand general practitioners. | Q39653584 |
| | Prostate-specific antigen testing: uncovering primary care influences | Q39771290 |
| | Survey of the rate of PSA testing in general practice | Q40688697 |
| | Cancer incidence and mortality, 1973-1995: a report card for the U.S. | Q40867044 |
| | Population-based prostate cancer trends in the United States: patterns of change in the era of prostate-specific antigen | Q41685647 |
| | Screening for prostate cancer in the UK. Seems to be creeping in by the back door | Q42774094 |
| | GP and patient predictors of PSA screening in Australian general practice | Q44435149 |
| | Trends in prostate cancer epidemiology in the year 2000. | Q44760664 |
| | Practitioner-level determinants of inappropriate prostate-specific antigen screening | Q45305640 |
| | PSA screening among elderly men with limited life expectancies. | Q46037181 |
| | A simple method of sample size calculation for linear and logistic regression | Q46204528 |
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 3 | |
| P577 | publication date | 2009-01-12 | |
| P1433 | published in | BMC Family Practice | Q15753454 |
| P1476 | title | Factors prompting PSA-testing of asymptomatic men in a country with no guidelines: a national survey of general practitioners | |
| P478 | volume | 10 | |